Multiple sclerosis: MRI-the perfect surrogate marker for multiple sclerosis?

Nature Reviews Neurology

Volumn 5, Issue 4, 2009, Pages 182-183

  Barkhof, Frederik ^a   Filippi, Massimo ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ARTICLE; BRAIN REGION; DIAGNOSTIC VALUE; DISABILITY; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL LESION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SENSITIVITY ANALYSIS; BRAIN; METHODOLOGY; NOTE; PATHOLOGY; PATHOPHYSIOLOGY;

BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 67649210709     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2009.31     Document Type: Article

References (13)

1. Youl, B. D. et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 114, 2437-2450 (1991).
2. Thorpe, J. W. et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 46, 373-378 (1996).
3. Rocca, M. A. et al. Cortical adaptation in patients with MS: A cross-sectional functional MRI study of disease phenotypes. Lancet Neurol. 4, 618-626 (2005).
4. McDonald, W. I. et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple sclerosis. Ann. Neurol. 50, 121-127 (2001).
5. Fisniku, L. K. et al. Disability and T2 MRI lesions: A 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 131, 808-817 (2008).
6. Daumer, M., Neuhaus, A., Morrissey, S., Hintzen, R. & Ebers, G. C. MRI as an outcome in multiple sclerosis clinical trials. Neurology doi:10.1212/01.wnl.0000336916.38629.43 (2008).
7. Schach, S., Scholz, M., Wolinsky, J. S. & Kappos, L. Pooled historical MRI data as a basis for research in multiple sclerosis - a statistical evaluation. Mult. Scler. 13, 509-516 (2007).
8. Ebers, G. C., Heigenhauser, L., Daumer, M., Lederer, C. & Noseworthy, J. H. Disability as an outcome in MS clinical trials. Neurology 71 624-631 (2008).
9. Goodin, D. S. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: Have we been overly harsh in our assessment? Ann. Neurol. 59, 597-605 (2006).
10. Sormani, M. P. et al. Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach. Ann. Neurol. (in press).
11. Bakshi, R. et al. MRI in multiple sclerosis: Current status and future prospects. Lancet Neurol. 7, 615-625 (2008).
12. Kalkers, N. F. et al. Concurrent validity of the MS Functional Composite using MRI as a biological disease marker. Neurology 56, 215-219 (2001).
13. Fisher, E. et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 59, 1412-1420 (2002).